Skip to main content

Metastatic urothelial carcinoma: the standard of care is about to change

Intervista a Andrea B. Apolo By 22 Ottobre 2023No Comments
Congressi

EV-302/KEYNOTE-A39 and CheckMate 901 could really change clinical practice in metastatic urothelial carcinoma. Andrea B. Apolo (Senior Investigator National Cancer Institute – NCI, Bethesda) explained us why when we met her at ESMO 2023 Congress in Madrid.